QA: Werewolf Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001785530_2024_Werewolf_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001785530, Werewolf Therapeutics Inc

  xvar xval
0 AssetsCurrent 138,370,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,958,000
3 remainder_Assets 28,505,000
4 LiabilitiesCurrent 19,378,000
5 LiabilitiesNoncurrent 11,425,000
6 remainder_Liabilities 32,656,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,670,000
9 ResearchAndDevelopmentExpense 41,776,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 23,078,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 174,833,000
1 Liabilities 63,459,000
2 Expenses 60,446,000
3 Revenues 0
4 StockholdersEquity 111,374,000
5 NetIncome -37,368,000
6 ComprehensiveNetIncome -37,368,000
7 BaseVar 160,908,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.72
9 EconomicCapitalRatio 2.84

Edgar->Model Mapping

Feature Distribution

Change over Time